InsidersTradesSigma
Track the ANI Pharmaceuticals, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €1.7bn. The latest transaction was reported on 7 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: PATRICK WALSH. The full history is openly available.
Analysts rate ANI Pharmaceuticals, Inc. Buy (bullish), based on 8 analysts. Average price target: US$108.38.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
ANI Pharmaceuticals, Inc. 是一家制药公司，专注于仿制药和品牌药的开发与商业化。该公司在纳斯达克上市，股票代码为 ANIP。